Chapter 1: Human papillomavirus and cervical cancer--burden and assessment of causality.

By F. Bosch, S. de Sanjosé. Journal of the National Cancer Institute. Monographs, 2003

926 citations recorded by the source corpus.

Subfields: Epidemiology, Surgery

View Paper: https://www.semanticscholar.org/paper/930c066c996011fcdc7f5e40a4229a0737f80f6c

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. L. Markowitz
2. Eileen F. Dunne
3. E. Unger
4. G. Mcquillan
5. C. Meyers
6. J. Rader
7. D. Swan
8. Robert Lu

Citations in the corpus

• Aberrant Expression of Oncogenic and Tumor-Suppressive MicroRNAs in Cervical Cancer Is Required for Cancer Cell Growth (2008, background): “cases and approximately 233,000 deaths per year [1,2].”
• Prevalence of HPV infection among females in the United States. (2007, background): “High-risk HPV types are detected in 99% of cervical cancers, and worldwide approximately 70% of cervical cancers are due to HPV types 16 and 18.(7,8) Although HPV infection is common, studies suggest approximately 90% of infections clear within 2 years.”